Fabrizio  D'Ascenzo (@fabri84dascenzo) 's Twitter Profile
Fabrizio D'Ascenzo

@fabri84dascenzo

Interventional Cardiologist and Researcher at University of Turin.

ID: 354804125

linkhttp://www.cardiogroup.org calendar_today14-08-2011 09:51:07

428 Tweet

1,1K Followers

1,1K Following

Florian Wenzl (@wenzl_florian) 's Twitter Profile Photo

Not what it used to be. Seminal work by Victor Schweiger, Davide Di Vece & Christian Templin shows increasing rates of cardiogenic #shock and #mortality in Takotsubo Syndrome! 🔥 JACC Journals EHJ Editor-in-Chief Fabrizio D'Ascenzo @DavidNiederseer Luca Liberale Holger Thiele SwissCardio

Susie Sun (@susiesu11733465) 's Twitter Profile Photo

#RCM Volume 25 / Issue 9 - Review: 🌻"Advances in the Management of Spontaneous Coronary Artery Dissection (#SCAD): A Comprehensive Review" by Dr. Federico Giacobbe Federico Giacobbe et al. #ACS #acutecoronarysyndrome #APT #PCI 🔗Welcome to read: imrpress.com/journal/RCM/25…

#RCM Volume 25 / Issue 9 - Review:

🌻"Advances in the Management of Spontaneous Coronary Artery Dissection (#SCAD): A Comprehensive Review" by Dr. Federico Giacobbe <a href="/fedegcb/">Federico Giacobbe</a> et al.

#ACS #acutecoronarysyndrome #APT #PCI 

🔗Welcome to read:
imrpress.com/journal/RCM/25…
EuroIntervention (@eurointerventio) 's Twitter Profile Photo

NEW ISSUE OUT 🔈 ✅ Sirolimus- versus paclitaxel-coated balloons in the treatment of coronary lesions; ✅ Natural history of newly developing calcified nodules; ✅ Treating DES restenosis with either ultrathin-strut vs thin-strut DES vs drug-eluting balloons; ✅

NEW ISSUE OUT 🔈  

✅ Sirolimus- versus paclitaxel-coated balloons in the treatment of coronary lesions;   
✅ Natural history of newly developing calcified nodules;   
✅ Treating DES restenosis with either ultrathin-strut vs thin-strut DES vs drug-eluting balloons;   
✅
Francesco Bruno (@cescobruno) 's Twitter Profile Photo

🌐 Data from the ULTRA-BIFURCAT registry 📍6830 bifurcations 📌IVUS ⬇️ MACE in left main 📌IVUS ⬇️ ST in non-left main bifurcations #imagingfirst Fabrizio D'Ascenzo Ovidio De Filippo

Stefano Cacciatore, MD (@stecacmd) 's Twitter Profile Photo

In-Hospital Bleeding and One-Year Outcomes in Acute Coronary Syndrome Patients: A PRAISE Registry Analysis 🩸 🫀 Our latest study, led by Luigi Spadafora and published in the Journal of Cardiovascular Pharmacology Journal of Cardiovascular Pharmacology, investigates the impact of in-hospital bleeding

In-Hospital Bleeding and One-Year Outcomes in Acute Coronary Syndrome Patients: A PRAISE Registry Analysis 🩸 🫀

Our latest study, led by <a href="/LuigiSpadafora/">Luigi Spadafora</a> and published in the Journal of Cardiovascular Pharmacology <a href="/JCVPOnline/">Journal of Cardiovascular Pharmacology</a>, investigates the impact of in-hospital bleeding
Mamas A. Mamas (@mmamas1973) 's Twitter Profile Photo

How do you decide the optimal antiplatelet duration in cancer patients post AMI? we published the PRECISE-DAPT cancer score a few months ago: academic.oup.com/eurheartj/arti… today we publish the validation in the international BLEEMACS registry with Mo Daf Francesco Costa Evan Kontopantelis

Fabrizio  D'Ascenzo (@fabri84dascenzo) 's Twitter Profile Photo

The countdown to the PULSE RCT presentation at the #ESC2025 is started! 🔥-5 days 🔥 Join us Sunday 31 Aug, 8.30 am in the Hot-Line session 6 in the main arena 📢📢 Ovidio De Filippo will present the main results of this RCT comparing CT-angio vs standard of care after LM PCI

The countdown to the PULSE  RCT presentation at the #ESC2025 is started! 🔥-5 days 🔥

Join us Sunday 31 Aug, 8.30 am in the Hot-Line session 6 in the main arena 📢📢
<a href="/ovidio_def/">Ovidio De Filippo</a>  will present the main results of this RCT comparing CT-angio vs standard of care after LM PCI
Fabrizio  D'Ascenzo (@fabri84dascenzo) 's Twitter Profile Photo

🔥Tomorrow is the day! -1 📌The results of the PULSE trial will be presented in the HOT line session 6 at 8.30 am See you there in Main arena Madrid 🙌🏻

🔥Tomorrow is the day! -1

📌The results of the PULSE trial will be presented in the HOT line session 6 at 8.30 am 

See you there in Main arena Madrid 🙌🏻
Francesco Bruno (@cescobruno) 's Twitter Profile Photo

📣📣Don’t miss tomorrow morning the presentation of our trial PULSE in Hot line 6 at 8.30 am at the #ESCCongress 🌐The PULSE trial compared CCTA control at 6 months vs standard of care after LM PCI Ovidio De Filippo will present the main results Gregg W. Stone MD will discuss it

JACC Journals (@jaccjournals) 's Twitter Profile Photo

Routine CCTA after LM #PCI did not reduce the composite primary endpoint, but was associated with fewer spontaneous MIs & more imaging-triggered revascularizations. Future trials are warranted. jacc.org/doi/10.1016/j.… #JACC #ESCCongress #WCCardio #cvMI #cvImaging

Routine CCTA after LM #PCI did not reduce the composite primary endpoint, but was associated with fewer spontaneous MIs &amp; more imaging-triggered revascularizations. Future trials are warranted. jacc.org/doi/10.1016/j.…

#JACC #ESCCongress #WCCardio #cvMI #cvImaging
Francesco Bruno (@cescobruno) 's Twitter Profile Photo

A main milestone for our group to present in the main arena in🔥HOTline 6 at the #ESCCongress and sim pub in #JACC 💊Our PULSE RCT 🌐606 patients with LM PCI 🏥6-months routine CCTA vs standard FU Compared to standard FU: 📌CCTA group ↔️MACE 📌CCTA group ⬇️Spontaneous MI

A main milestone for our group to present in the main arena in🔥HOTline 6  at the #ESCCongress and sim pub in #JACC

💊Our PULSE RCT 
🌐606 patients with LM PCI
🏥6-months routine CCTA vs standard FU
Compared to standard FU: 
📌CCTA group ↔️MACE 
📌CCTA group ⬇️Spontaneous MI
Fabrizio  D'Ascenzo (@fabri84dascenzo) 's Twitter Profile Photo

The PULSE RCT is out in #JACC TV. Check out the full interview👇🏻 🌐 youtu.be/9lns3yoMKto?si… 👉🏻jacc.org/digital-conten…

The PULSE RCT is out in #JACC TV.
Check out the full interview👇🏻

🌐 youtu.be/9lns3yoMKto?si… 

👉🏻jacc.org/digital-conten…
Florian Wenzl (@wenzl_florian) 's Twitter Profile Photo

Our article published in The Lancet Digital Health uses #AI on data from >600 000 patients with NSTE-ACS across 10 countries to extend and validate the #GRACE score with 1-year mortality & #individualised treatment effect models 🌐 grace-3.com 👉 doi.org/10.1016/j.land…

Our article published in <a href="/LancetDigitalH/">The Lancet Digital Health</a> uses #AI on data from &gt;600 000 patients with NSTE-ACS across 10 countries to extend and validate the #GRACE score with 1-year mortality &amp; #individualised treatment effect models

🌐 grace-3.com

👉 doi.org/10.1016/j.land…